ABN AMRO INVESTMENT SOLUTIONS

Position in BSX — Boston Scientific Corp

CIK 2080520 PARIS CEDEX 008, I0

Position in BSX

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$5,156,469

-$50,961,483 QoQ

Shares Held

120,817

-86.5% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#415

of 1,468 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ABN AMRO INVESTMENT SOLUTIONS holds $204,884,588 across 10 Medical Devices names. BSX ranks #5 (2.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SYK	Stryker Corp	414,338	$130,450,175
2	EW	Edwards Lifesciences Corp	425,838	$38,521,304
3	MDT	Medtronic plc	176,006	$13,768,948
4	ABT	Abbott Laboratories	111,702	$10,135,839
5	BSX	Boston Scientific Corp This page	120,817	$5,156,469
6	DXCM	Dexcom Inc	43,326	$2,918,006
7	IRTC	iRhythm Holdings, Inc.	11,500	$1,367,925
8	STE	STERIS plc	5,414	$1,140,025

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,156,469	120,817	-86.5%	Shares	Other	2026-07-23
2026-03-31	$56,117,952	894,310	+30.2%	Shares	Defined	2026-05-12
2025-12-31	$65,506,116	687,007	+22.5%	Shares	Other	2026-02-06
2025-09-30	$54,762,521	560,919	+540.1%	Shares	Defined	2025-11-07
2025-06-30	$9,412,982	87,636	-8.0%	Shares	Defined	2025-08-08
2025-03-31	$9,604,583	95,208	+9.1%	Shares	Defined	2025-08-27
2024-12-31	$7,791,115	87,227	+7.9%	Shares	Defined	2025-09-04
2024-09-30	$6,776,151	80,861	+0.9%	Shares	Defined	2025-09-04
2024-06-30	$6,169,040	80,107	+77.5%	Shares	Defined	2025-09-04
2024-03-31	$3,091,844	45,143	+2.8%	Shares	Defined	2025-09-05
2023-12-31	$2,539,651	43,931	-1.8%	Shares	Defined	2025-09-05
2023-09-30	$2,362,272	44,740	+41.0%	Shares	Defined	2025-11-07
2023-06-30	$1,715,951	31,724	+3.2%	Shares	Defined	2025-09-05
2023-03-31	$1,537,722	30,736	—	Shares	Defined	2025-09-05
No filing history on record for this holder in this stock.